Vision Retirement’s AbbVie ABBV Stock Holding History

Vision Retirement’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$167K	Sell	664 -4	-0.6%	-$861	0.04%	141
2026 Q1	$145K	Sell	668 -10	-1%	-$2.22K	0.04%	137
2025 Q4	$155K	Buy	+678	New	+$154K	0.04%	139

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vision Retirement's ABBV Position: Q2 2026 in Review

Vision Retirement reduced its AbbVie (ABBV) stake by 0.6% in Q2 2026, selling an estimated $861 and leaving 664 shares worth $167K. The position accounts for 0.04% of the portfolio, ranked #141.

Vision Retirement first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Vision Retirement held 664 shares of AbbVie worth $167K as of Q2 2026.
Vision Retirement sold 4 AbbVie shares in Q2 2026, an estimated $861.
AbbVie made up 0.04% of Vision Retirement's portfolio in Q2 2026, its #141 holding.
Vision Retirement first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vision Retirement's 13F filing for Q2 2026, filed 21 Jul 2026.